RMB acted as Financial Adviser, Transaction Sponsor, Corporate Broker, Hedge Advisor and Hedge Coordinator to Aspen Pharmacare Holdings Limited (Aspen) on the divestment of its Asia-Pacific (APAC) businesses (excluding China) and associated intellectual property across multiple markets in the region.

The transaction, valued at AUD 2.37 billion, enabled Aspen to unlock significant value from its APAC portfolio while improving balance sheet flexibility and enabling the Group to have a heightened focus on its identified drivers of future growth and performance.

RMB’s role builds on a long-standing relationship with Aspen, developed over nearly two decades of supporting the Group’s treasury and management teams across funding, capital structure and strategic initiatives.

The challenge

The transaction involved the divestment of multiple businesses and intellectual property assets across Australia, New Zealand and Southeast Asia requiring coordination across the legal, regulatory and commercial aspects of the transaction.

Given the scale of the divestment, which accounts for a significant share of Aspen’s earnings, the transaction required clear articulation of its rationale, future direction and use of proceeds to shareholders.

The process also required careful management of regulatory approvals, change of control provisions and transaction timelines, including the preparation of a Category 1 circular and engagement with the Johannesburg Stock Exchange (JSE).

In parallel, Aspen needed to manage currency risk over the period between agreeing the transaction and receiving the proceeds, as fluctuations in exchange rates could have affected the value realised.

RMB’s solution

RMB supported Aspen across multiple aspects of the transaction. Working closely with Aspen’s management and treasury teams, RMB helped articulate the transaction rationale and position the divestment clearly to shareholders, supporting engagement throughout the process. As Transaction Sponsor, RMB advised on all key deliverables for a JSE Category 1 transaction and coordinated interactions with the JSE.

RMB also provided exchange control advice, guiding engagements with the South African Reserve Bank (SARB) and ensuring compliance with regulatory requirements. As Hedge Advisor, RMB advised on managing foreign exchange risk over the execution period, coordinating pricing across banks and implementing hedging strategies to protect transaction value.

RMB’s ability to deliver across multiple aspects of the transaction reflects its deep understanding of Aspen’s business, capital structure and strategic priorities, built through an enduring relationship and close engagement with Aspen’s management and treasury teams.

Results and benefits

The transaction enabled Aspen to unlock significant value from its APAC portfolio (excluding China) and use the proceeds primarily to reduce debt, lowering financing costs and improving balance sheet flexibility. The Group’s optimised balance sheet will position Aspen to better deliver on its strategic objectives and to drive value and returns for its shareholders.

For RMB, the transaction reflects its long-standing relationship with Aspen and its role as a trusted adviser to management and treasury. It demonstrates RMB’s ability to deliver complex, cross-border transactions that require coordination across multiple capabilities, combining strategic advisory, regulatory expertise and risk management.

Client Aspen Pharmacare Holdings Limited
Deal value AUD2.37 billion
Sector Healthcare (Pharmaceuticals)
Capabilities Corporate Finance, JSE Sponsor, Corporate Broking, Global Markets, Exchange Control
RMB's role Financial Adviser, Transaction Sponsor, Corporate Broker, Hedge Adviser, Hedge Co-ordinator
Geography South Africa/APAC

RMB has an extensive deal footprint in over 35 countries in Africa.

Subject
Your details
Required
Company turnover
Number of employees
Are you an existing client?
Required
Required
Required
Required
Required
Required
Required
Required

Thank you for your enquiry, your details have been submitted.

Connect with us on your favourite social platform

Explore some of our other solutions

More deals in Healthcare